TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ocumension Therapeutics ( (HK:1477) ) has shared an announcement.
Ocumension Therapeutics has announced its upcoming annual general meeting scheduled for June 19, 2025, in Shanghai. The meeting will address several key resolutions, including the adoption of the company’s financial statements for 2024, the re-election of directors, and the reappointment of Deloitte Touche Tohmatsu as auditors. Additionally, the meeting will consider authorizing the board to issue additional shares, which could impact the company’s capital structure and market operations.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, focusing on the development and commercialization of ophthalmic therapies. The company operates within the healthcare industry, specifically targeting eye-related medical treatments.
YTD Price Performance: 22.67%
Average Trading Volume: 3,224,624
Technical Sentiment Signal: Hold
Current Market Cap: HK$4.53B
For an in-depth examination of 1477 stock, go to TipRanks’ Stock Analysis page.